Glycomics statistics
Differential abundance, motif enrichment and time-series analysis for N- and O-glycomics, built on compositional data analysis so results hold up to scrutiny.
SweetSense Analytics gives biotech and pharma teams direct access to the methods behind glycowork, CandyCrunch and LectinOracle, applied by the scientist who built them.
Six areas where glycoscience questions stall most teams, and where our methods move them forward.
Differential abundance, motif enrichment and time-series analysis for N- and O-glycomics, built on compositional data analysis so results hold up to scrutiny.
Deep-learning annotation of tandem mass spectra into full glycan structures with CandyCrunch, including diagnostic ion analysis for difficult isomers.
Predict and interpret how lectins, antibodies and microbial adhesins recognize glycans, from array data to target-level specificity maps.
Trace a glycome shift back to the enzymes and pathways that drive it, to guide cell line engineering or explain a disease phenotype.
Glycan conformations and protein-glycan contacts analyzed across thousands of structures with GlyContact, for glycoprotein design and epitope work.
Machine learning models, curated datasets and pipelines built for your glycan or glycoprotein question, delivered as code your team owns.
Focused sessions on a specific question: data review, method choice or a second opinion before a decision.
A standing monthly arrangement for companies that need regular glycoscience input. Equity can form part of it.
An agreed analysis with clear deliverables: a report, publication-quality figures and reproducible code.
The software behind our work is open source and used by glycobiology labs and companies worldwide. You get the people who wrote it.
Associate Professor of Bioinformatics at the University of Gothenburg and Deputy Director of the Centre for Modelling Life at the Membrane with AI (CEMERAI). Trained at ETH Zurich and at MIT and the Wyss Institute at Harvard. His lab develops widely used machine learning methods for glycobiology.
Current and past clients include pharmaceutical companies and venture-backed biotech in Europe and the US.
Send a short description of your question, your data type and your timeline.
daniel@bojar.net